Elevated circulating magnesium levels in patients with Parkinson’s disease: a meta-analysis

QR Code

Elevated circulating magnesium levels in patients with Parkinson’s disease: a meta-analysis

Xin Jin,1 Ming-Yan Liu,2 Dong-Fang Zhang,1 Hua Gao,3 Min-Jie Wei2,4 1School of Pharmacy, Department of Pharmacognosy, China Medical University, Shenyang, Liaoning, China; 2School of Pharmacy, Department of Pharmacology, China Medical University, Shenyang, Liaoning, China; 3Division of Pharmacology...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Jin X, Liu MY, Zhang DF, Gao H, Wei MJ
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2018
Sujets:	magnesium serum peripheral blood CSF Parkinson's disease meta-analysis Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Accès en ligne:	https://doaj.org/article/a1aed2bd5b88456ab3a408d95825a3a8
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Treatment Of Magnesium-L-Threonate Elevates The Magnesium Level In The Cerebrospinal Fluid And Attenuates Motor Deficits And Dopamine Neuron Loss In A Mouse Model Of Parkinson’s disease
par: Shen Y, et autres
Publié: (2019)

Atypical antipsychotics for Parkinson’s disease psychosis: a systematic review and meta-analysis
par: Zhang H, et autres
Publié: (2019)

Alterations of the serum and CSF ferritin levels and the diagnosis and prognosis of amyotrophic lateral sclerosis
par: Parastou Paydarnia, et autres
Publié: (2021)

Effectiveness of high-frequency repetitive transcranial magnetic stimulation in patients with depression and Parkinson’s disease: a meta-analysis of randomized, controlled clinical trials
par: Qin B, et autres
Publié: (2018)

Low levels of serum magnesium are associated with poststroke cognitive impairment in ischemic stroke patients
par: Tu X, et autres
Publié: (2018)

Effect of Acupuncture on Movement Function in Patients with Parkinson’s Disease: Network Meta-Analysis of Randomized Controlled Trials
par: Miri Kwon, et autres
Publié: (2021)

Human Adipose Tissue-Derived Mesenchymal Stem Cells in Parkinson’s Disease: Inhibition of T Helper 17 Cell Differentiation and Regulation of Immune Balance Towards a Regulatory T Cell Phenotype
par: Bi Y, et autres
Publié: (2020)

Causal Effect of Serum Magnesium on Osteoporosis and Cardiometabolic Diseases
par: Bin He, et autres
Publié: (2021)

Rasagiline for sleep disorders in patients with Parkinson’s disease: a prospective observational study
par: Schettino C, et autres
Publié: (2016)

Bright Light Therapy for Parkinson Disease: A Literature Review and Meta-Analysis of Randomized Controlled Trials
par: Hsu-Tung Huang, et autres
Publié: (2021)

The role of rasagiline in the treatment of Parkinson’s disease
par: Julie Leegwater-Kim, et autres
Publié: (2010)

Parkinson's disease

Vitamin D, Magnesium and Their Interactions: A Review
par: Zeinab Shahsavani, et autres
Publié: (2021)

Odor selectivity of hyposmia and cognitive impairment in patients with Parkinson’s disease
par: Mao CJ, et autres
Publié: (2017)

Neuropsychiatric symptoms in untreated Parkinson’s disease
par: Szatmari S, et autres
Publié: (2017)

Systematic review on strength training in Parkinson’s disease: an unsolved question
par: Ramazzina I, et autres
Publié: (2017)

Altered emotional recognition and expression in patients with Parkinson’s disease
par: Jin Y, et autres
Publié: (2017)

Oral Magnesium Supplementation for Treating Glucose Metabolism Parameters in People with or at Risk of Diabetes: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials
par: Nicola Veronese, et autres
Publié: (2021)

Update on the treatment of Parkinson’s disease psychosis: role of pimavanserin
par: Combs BL, et autres
Publié: (2017)

Levodopa in the treatment of Parkinson’s disease: an old drug still going strong
par: Werner Poewe, et autres
Publié: (2010)

The association between CD157/BST1 polymorphisms and the susceptibility of Parkinson’s disease: a meta-analysis
par: Li J, et autres
Publié: (2019)

Cytological and cytometric analysis of oral mucosa in patients with Alzheimer’s and Parkinson’s disease
par: Kose Ozlece H, et autres
Publié: (2018)

A practical method for the detection of freezing of gait in patients with Parkinson’s disease
par: Kwon Y, et autres
Publié: (2014)

Parkinson’s disease managing reversible neurodegeneration
par: Hinz M, et autres
Publié: (2016)

Neuroprotective effect and mechanism of baicalin on Parkinson’s disease model induced by 6-OHDA
par: Tu L, et autres
Publié: (2020)

Sleep apnea leading to Parkinson’s disease – an important association
par: Shafqat MN, et autres
Publié: (2017)

Parkinson’s Disease Managing Reversible Neurodegeneration [Retraction]
par: Hinz M, et autres
Publié: (2020)

Psychosis in parkinsonism: an unorthodox approach
par: Onofrj M, et autres
Publié: (2017)

Cortical Activation During Finger Tapping Task Performance in Parkinson's Disease Is Influenced by Priming Conditions: An ALE Meta-Analysis
par: Jingjing Li, et autres
Publié: (2021)

Minimum Alveolar Concentration-Awake of Sevoflurane is Decreased in Patients with Parkinson’s Disease: An Up-and-Down Sequential Allocation Trial
par: Yang C, et autres
Publié: (2021)

Clinical study of the effects of deep brain stimulation on urinary dysfunctions in patients with Parkinson’s disease
par: Zong H, et autres
Publié: (2019)

Journal of Parkinson's disease

Parkinson’s Disease Managing Reversible Neurodegeneration [Expression of Concern]
par: Hinz M, et autres
Publié: (2020)

Neurofilament Levels Are Reflecting the Loss of Presynaptic Dopamine Receptors in Movement Disorders
par: Elena Diekämper, et autres
Publié: (2021)

Different protocols for analyzing behavior and adaptability in obstacle crossing in Parkinson’s disease
par: Mollaei N, et autres
Publié: (2017)

Impact of Supporting People with Advanced Parkinson’s Disease on Carer’s Quality of Life and Burden
par: Modugno N, et autres
Publié: (2020)

Progressive Resistance Training Improves Bradykinesia, Motor Symptoms and Functional Performance in Patients with Parkinson’s Disease
par: Vieira de Moraes Filho A, et autres
Publié: (2020)

The role of deep brain stimulation in Parkinson’s disease: an overview and update on new developments
par: Fang JY, et autres
Publié: (2017)

A review of ropinirole prolonged release in Parkinson’s disease
par: Muhammad M Nashatizadeh, et autres
Publié: (2009)

Altered emotional prosody processing in patients with Parkinson’s disease after subthalamic nucleus stimulation
par: Jin Y, et autres
Publié: (2017)